The Global Fund is the single most powerful tool in the fight against HIV/AIDS, tuberculosis and malaria — three deadly diseases that collectively claim the lives of more than 3 million people each year. Through innovative partnerships with governments, civil society, the private sector, and affected communities, the Global Fund channels resources to country-driven programs to deliver essential treatment, prevention and care services. Since 2002, programs supported by the Global Fund have saved an estimated 8.7 million lives.
Unique Attributes of the Global Fund
The Global Fund’s pioneering approach allows resources to be delivered to locally-owned programs in a cost-effective, participatory and accountable manner. Several unique attributes of the Global Fund make this possible:
Performance-based funding: Funding is released incrementally based on demonstrated results against agreed targets (e.g. delivering tangible services such as bed nets or anti-AIDS drugs). The Fund stops, reduces or accelerates grants based on their demonstrated performance against these targets.
Country Ownership: Country-level structures allow recipient nations to design programs and allocate funds in accordance with their national health priorities. Applications and implementation are carried out by local partnerships among governments, health experts, civil society, faith-based organizations and the private sector.
Low Overhead: Exceptionally low overhead costs mean that virtually all funds are delivered to the people who need them. The Fund estimates that 97 cents of every dollar raised goes directly to grants.
Transparency: All proposals, applications, grant agreements and progress reports are published on the Global Fund’s website.
Since its establishment, the Global Fund has signed grant agreements worth $22.9 billion across 151 countries. To date, the Global Fund has achieved the following results globally:
Antiretroviral treatment for 4.2 million people with HIV
Detection and treatment of 9.7 million TB cases
310 million insecticide-treated bed nets to protect families from malaria
260 million treatments for people with malaria
250 million HIV counseling and testing encounters
A complete course of ARV prophylaxis to reduce mother-to-child transmission for 1.7 million HIV-positive pregnant women
Basic care and support for 4.9 million orphans
Training for 11.3 million health or community workers to deliver services
The Global Fund’s 2012-2016 Strategy: Investing for Impact
The Global Fund aims to build on its first decade of impressive results by outlining new targets as part of its 2012-2016 strategy. If fully funded and implemented, the Global Fund’s strategy will help save 10 million lives and prevent 140-180 million new infections from HIV/AIDS, tuberculosis and malaria between 2012 and 2016. These goals are complemented by disease-specific targets aligned with the global targets set by UNAIDS, the World Health Organization, and the Stop TB and Roll Back Malaria partnerships.
To achieve this, the Global Fund will “invest for impact” based on five strategic objectives:
Invest more strategically in areas with high potential for impact and strong value for money, and fund based on countries’ national strategies;
Provide funding in a more proactive, flexible, predictable and effective way;
Actively support grant implementation success through more active grant management and better engagement with partners;
Promote and protect human rights in the context of the three diseases; and
Sustains the gains, mobilize resources – by increasing the sustainability of supported programs and attracting additional funding from current and new sources.
Ultimately, if donors, recipients, and the private sector step up their support for the Global Fund in the coming years, the Global Fund will continue to play a leading role in driving toward key global health milestones: the end of malaria deaths, the end of mother-to-child transmission of HIV, the control of TB, and the beginning of the end of AIDS.
ONE welcomes European Commission President José Manuel Barroso and Development Commissioner Andris Piebalgs’s renewed support for critical global health initiatives announced today at the Global Vaccine Summit in Abu Dhabi, United Arab Emirates. In a speech, President Barroso reaffirmed the EU’s commitment to the GAVI vaccines alliance as well as treatments for HIV/AIDS, Tuberculosis and Malaria through the Global Fund.
AIDS used to be a death sentence, but now more than 8 million people are on life-saving treatment. By 2015, with the scale up of treatment and prevention for HIV, we could see the beginning of the end of AIDS. It Starts With You. Tell World Leaders to keep up the fight.
ONE's accountability report monitors progress made towards the beginning of the end of AIDS. Specifically, the report tracks progress made on three key targets - the virtual elimination of mother-to-child transmission, 15 million people on treatment, and the drastic reduction of new HIV infections - and assesses the political, programmatic, and financial contributions made by a variety of stakeholders.
Scientists have the tools to turn the tide on the AIDS pandemic, but will fail unless funding, coordination and political will to support effective AIDS programs are stepped up around the world, a new report published today by ONE has found.
Ahead of World AIDS Day on 1 December, ONE is calling on the European Union to maintain funding for lifesaving AIDS programmes as new research shows the world is off-track for achieving key targets for the year 2015.
As the Chancellor prepares to set out his spending plans in Wednesday's Budget, new research by the anti-poverty organisation ONE reveals for the first time the expected impact of the UK aid budget. The new audit of UK aid spending plans shows that UK aid will put 15.9 million children in school, protect 5.8 million mothers during childbirth and help over 9 million people overcome malnutrition in the next four years.